within Pharmacolibrary.Drugs.D_Dermatologicals.D05A_AntipsoriaticsForTopicalUse.D05AX02_Calcipotriol;

model Calcipotriol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C(
    weight = 70,
    F = 1,
    Cl = 3.6111111111111115e-06,
    adminDuration = 600,
    adminMass = 50 / 1000000,
    adminCount = 1,
    Vd = 0.05,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Calcipotriol</td></tr><tr><td>ATC code:</td><td>D05AX02</td></tr><td>route:</td><td>topical</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>50</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>50</td><td>L</td></tr>
    <tr><td>clearance:</td><td>13</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Calcipotriol (calcipotriene) is a synthetic derivative of vitamin D3 used primarily as a topical treatment for psoriasis. It modulates keratinocyte proliferation and differentiation and is approved for clinical use in several countries.</p><h4>Pharmacokinetics</h4><p>PK parameters are based on estimated data as no direct human systemic pharmacokinetic studies have been published due to the drug's topical use and low systemic absorption. Estimates relate to typical adult patients using the drug topically.</p><h4>References</h4><ol><li><p>Dai, X, et al., &amp; Donnelly, RF (2024). Calcipotriol Nanosuspension-Loaded Trilayer Dissolving Microneedle Patches for the Treatment of Psoriasis: In Vitro Delivery and In Vivo Antipsoriatic Activity Studies. <i>Molecular pharmaceutics</i> 21(6) 2813–2827. DOI:<a href=\"https://doi.org/10.1021/acs.molpharmaceut.3c01223\">10.1021/acs.molpharmaceut.3c01223</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38752564/\">https://pubmed.ncbi.nlm.nih.gov/38752564</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.D.D05AX02 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Calcipotriol;
